Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review. - Wikidata - wikimedia - TriplyDB

Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review.

Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review.

http://www.wikidata.org/entity/Q34022283

about

Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?Excess cardiovascular risk in diabetic women: a case for intensive treatment.

P2860

Q30234825-E873F5BB-E63C-4D02-944E-9BCC11CA092C Q35533775-E4A16BB5-6838-4D81-A860-370AA3ED67C6

P2860

Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review.

http://www.wikidata.org/entity/Q34022283

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Coronary Heart Disease in Post ...... t Therapy: A Narrative Review.

@ast

Coronary Heart Disease in Post ...... t Therapy: A Narrative Review.

@en

Coronary Heart Disease in Post ...... t Therapy: A Narrative Review.

@nl

type

label

Coronary Heart Disease in Post ...... t Therapy: A Narrative Review.

@ast

Coronary Heart Disease in Post ...... t Therapy: A Narrative Review.

@en

Coronary Heart Disease in Post ...... t Therapy: A Narrative Review.

@nl

prefLabel

Coronary Heart Disease in Post ...... t Therapy: A Narrative Review.

@ast

Coronary Heart Disease in Post ...... t Therapy: A Narrative Review.

@en

Coronary Heart Disease in Post ...... t Therapy: A Narrative Review.

@nl

P1433

Q34022283-EBE84915-5C26-4CAC-848F-9EAC18F16A08

P1476

Q34022283-68721456-0EE7-4658-9FA3-9747B47DAFE0

P2093

Q34022283-3C432E59-0462-4661-978B-5C2E340CAB96

Q34022283-A6DBDB4A-A4A3-4818-B280-F1565336CB6E

Q34022283-C8F5380C-FDAA-4799-8205-25A8EADE894C

P2860

Q34022283-0430E484-C1F9-4960-9011-2B8A7F129B49

Q34022283-0A59A5F3-768A-4860-A1B2-CE93FFF320E5

Q34022283-0EA3AF6C-A620-44E4-9AAE-AD88EB630BF6

Q34022283-18C0661C-7CE9-4848-B84B-52CB0A7C8F3B

Q34022283-218B97C9-3828-4149-877F-025CC6F685EA

Q34022283-21AF141E-C7F2-4DE1-B76C-55B9DE0B58BC

Q34022283-40E50A83-636E-4190-914E-E4FBDF0F745E

Q34022283-44D2E251-57AD-4A9E-BA92-600E364F7594

Q34022283-48238890-4FB1-4EA0-A53A-17AAD3FE8E84

Q34022283-49784ED0-D851-4DE2-BD06-FCBB0D9D20F9

P304

Q34022283-6A6BBC92-2FD3-4FDD-A4C4-428C483C2EFB

P31

Q34022283-1AD23DF4-D4FA-4C80-8BC7-C831012BEB96

P356

Q34022283-408941FA-35C7-47AF-AE98-AF4D9156BCB5

P478

Q34022283-F9E594CD-EBC5-480F-982C-2FF4CD4B5E8B

P50

Q34022283-5024D4E8-F369-4944-AE0D-229BD6E900A0

Q34022283-BF46FC81-DACF-437E-8295-0C7F7EBC6A85

Q34022283-C4FB6B38-C8E1-40AD-A77A-C0365D707B4B

P577

Q34022283-9E9F7A79-C946-401F-9D88-BBD67FDB58FE

P5875

Q34022283-4CE131F9-5DC4-4FE9-9E13-B33F8985A0B8

P698

Q34022283-826D144F-E9AB-4FA5-8DD5-0CD7F180EE79

P921

Q34022283-033DF000-C222-4459-B9CD-2B7DEA732F6F

P932

Q34022283-539F2D8D-82E5-4CF8-8645-AD935B6DC984

P356

P1433

International journal of endocrinology

P1476

Coronary Heart Disease in Post ...... nt Therapy: A Narrative Review

@en

P2093

Francesco Marzà

http://www.w3.org/2001/XMLSchema#string

Salvatore Davide Tomasello

http://www.w3.org/2001/XMLSchema#string

Sonia Bregante

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

Atherosclerosis — An Inflammatory Disease

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Coagulation activation following estrogen administration to postmenopausal women

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

Postmenopausal changes in serum cytokine levels and hormone replacement therapy.

Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

Therapeutic implications of inflammation in atherosclerotic cardiovascular disease.

P304

413920

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/413920

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

Alfredo R. Galassi

Francesca Romana Pluchinotta

Marouane Boukhris

P577

2014-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268808470

http://www.w3.org/2001/XMLSchema#string

P698

25136365

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4127220

http://www.w3.org/2001/XMLSchema#string